Free Trial

Victory Capital Management Inc. Has $101.50 Million Position in Innospec Inc. (NASDAQ:IOSP)

Innospec logo with Basic Materials background
Remove Ads

Victory Capital Management Inc. increased its position in Innospec Inc. (NASDAQ:IOSP - Free Report) by 1.6% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 922,220 shares of the specialty chemicals company's stock after acquiring an additional 14,188 shares during the period. Victory Capital Management Inc. owned approximately 3.70% of Innospec worth $101,500,000 as of its most recent SEC filing.

Several other hedge funds have also recently bought and sold shares of IOSP. Blue Trust Inc. grew its holdings in Innospec by 54.2% during the 4th quarter. Blue Trust Inc. now owns 1,201 shares of the specialty chemicals company's stock valued at $136,000 after buying an additional 422 shares during the last quarter. KBC Group NV lifted its position in shares of Innospec by 82.3% in the fourth quarter. KBC Group NV now owns 1,236 shares of the specialty chemicals company's stock valued at $136,000 after acquiring an additional 558 shares in the last quarter. Smartleaf Asset Management LLC boosted its stake in shares of Innospec by 91.9% during the fourth quarter. Smartleaf Asset Management LLC now owns 1,802 shares of the specialty chemicals company's stock valued at $198,000 after acquiring an additional 863 shares during the last quarter. Point72 Asset Management L.P. acquired a new stake in shares of Innospec during the third quarter valued at $215,000. Finally, Claro Advisors LLC purchased a new stake in Innospec during the 4th quarter worth about $220,000. 96.64% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at Innospec

In other Innospec news, VP Philip John Boon sold 3,754 shares of Innospec stock in a transaction on Friday, February 21st. The shares were sold at an average price of $103.30, for a total value of $387,788.20. Following the completion of the transaction, the vice president now owns 20,079 shares of the company's stock, valued at $2,074,160.70. The trade was a 15.75 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, SVP Corbin Barnes sold 2,692 shares of Innospec stock in a transaction dated Friday, February 21st. The shares were sold at an average price of $103.30, for a total transaction of $278,083.60. Following the completion of the transaction, the senior vice president now directly owns 8,051 shares of the company's stock, valued at $831,668.30. This trade represents a 25.06 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 7,696 shares of company stock worth $794,853 in the last ninety days. 1.52% of the stock is owned by insiders.

Remove Ads

Wall Street Analyst Weigh In

Separately, StockNews.com raised Innospec from a "hold" rating to a "buy" rating in a research note on Thursday.

Check Out Our Latest Research Report on IOSP

Innospec Stock Up 1.1 %

Shares of NASDAQ IOSP traded up $1.08 during midday trading on Friday, hitting $100.62. The stock had a trading volume of 176,607 shares, compared to its average volume of 149,289. Innospec Inc. has a 1-year low of $97.13 and a 1-year high of $133.71. The company has a market capitalization of $2.51 billion, a price-to-earnings ratio of 70.86 and a beta of 1.08. The company has a fifty day moving average price of $108.89 and a 200 day moving average price of $111.92.

Innospec (NASDAQ:IOSP - Get Free Report) last released its quarterly earnings results on Tuesday, February 18th. The specialty chemicals company reported $1.41 earnings per share for the quarter, topping analysts' consensus estimates of $1.36 by $0.05. The firm had revenue of $466.80 million during the quarter, compared to analysts' expectations of $447.43 million. Innospec had a return on equity of 12.27% and a net margin of 1.93%. On average, research analysts forecast that Innospec Inc. will post 6.18 EPS for the current year.

Innospec Company Profile

(Free Report)

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.

Featured Stories

Institutional Ownership by Quarter for Innospec (NASDAQ:IOSP)

Should You Invest $1,000 in Innospec Right Now?

Before you consider Innospec, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Innospec wasn't on the list.

While Innospec currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

Is There Still Money in AI? How to Invest in the Next Big Wave
AMD at Rock Bottom? Analysts Predict a MAJOR Rebound!
Massive Buybacks: 3 Stocks Insiders Are Buying Up

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads